UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.00-0.56 (-0.81%)
At close: 4:00PM EST
Currency in USD
Earnings estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts1091012
Avg. Estimate-0.13-0.2-0.55-0.64
Low estimate-0.38-0.4-1.16-2.3
High estimate0.01-0.011.861.31
Year ago EPS-0.2-0.13-0.84-0.55
Revenue estimateCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
No. of analysts88810
Avg. Estimate37.7M35.49M137.33M219.67M
Low estimate11.68M11.21M81.3M74.56M
High estimate55.7M58.9M198.2M390.4M
Year ago salesN/AN/A87.99M137.33M
Sales growth (year/est)N/AN/A56.10%60.00%
Earnings history30/03/202029/06/202029/09/202030/12/2020
Est. EPS-0.11-0.120.120.12
Actual EPS-0.2-0.13-0.48-0.2
Difference-0.09-0.01-0.6-0.32
Surprise %-81.80%-8.30%-500.00%-266.70%
EPS trendCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Current estimate-0.13-0.2-0.55-0.64
7 days ago-0.13-0.2-0.55-0.64
30 days ago-0.27-0.32-0.23-1.12
60 days ago-0.25-0.29-0.24-0.92
90 days ago-0.25-0.31-0.39-0.86
EPS revisionsCurrent qtr. (Mar 2021)Next qtr. (Jun 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days10887
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARWRIndustrySector(s)S&P 500
Current qtr.35.00%N/AN/AN/A
Next qtr.-53.80%N/AN/AN/A
Current year34.50%N/AN/AN/A
Next year-16.40%N/AN/AN/A
Next 5 years (per annum)7.33%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A